Tag: immunotherapy
UQ researchers develop nanotech to boost immunotherapy for breast cancer
Researchers at the University of Queensland are developing nanotechnology that could enhance the effectiveness of treatments for triple-negative breast cancer (TNBC), one of the most aggressive and difficult-to-treat forms of the disease.
Immutep gets green light for large-scale cancer product manufacturing for clinical trials
Immutep Limited, a clinical-stage biotechnology company specialising in LAG-3 immunotherapies for cancer and autoimmune diseases, has received regulatory authorisation for the commercial manufacturing of Eftilagimod Alpha (efti) at a scale of 2,000 litres for clinical trial use.
Featured Article
Australian Manufacturing Week 2026 enters final run-up to Brisbane debut
Australia’s manufacturing sector continues to play a critical role in the national economy, underpinned by ongoing investment in advanced technologies, automation, and high-value production.
